Title: Real-world disease burden and healthcare resource utilization among patients with COPD and asthma using triple therapy (FF/UMEC/VI) in the United States.
Citation: Int J Chron Obstruct Pulmon Dis
2024;19:281–296.
Country: USA |
Indication: COPD
|
Comorbidity: Asthma*
http://tago.ca/38292138
* FF/UMEC/VI is not approved for asthma treatment in Spain
* FF/UMEC/VI is not approved for asthma treatment in Spain
Scan to access the publication or visit
http://tago.ca/38292138
http://tago.ca/38292138